Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0WYDZZ
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
CN113813399A ADC:LN401-34-3
|
|||||
| Synonyms |
ADC:LN401-34-3
Click to Show/Hide
|
|||||
| Organization |
Levena Biopharma Co ltd
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
8
|
|||||
| Structure |
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TACSTD2)
|
Antigen Info | ||||
| Payload Name |
Active metabolite of irinotecan SN38
|
Payload Info | ||||
| Payload Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Linker Name |
CN113813399A-ADC:LN401-34-3-linker
|
Linker Info | ||||
| Conjugate Type |
Random conjugation through reduced inter-chain cysteines.
|
|||||
| Combination Type |
CN113813399A-ADC:LN401-34-3-linker-SN38
|
|||||